Traditional brick and mortar retailers seem to face more intense online competition every year. Given the challenging consumer spending environment��articularly during the highly promotional holiday shopping period��013 was an especially tough year for many.
The weak holiday sales have resulted in numerous downgrades of retail stocks. Among them was PetSmart (PETM), the leading retailer of pet products and services in North America, which was downgraded by several analysts last month, citing weaker holiday traffic trends and expectations for increased online competition ahead.
However, PETM has been fairly unscathed by the growing dominance of online retailers over the years. The simple reason for this is the fact that no one has been able to stay in the business of selling 50 pound bags of dog food at a discount while also providing free shipping for very long. Additionally, demand for its products tends to be fairly inelastic and less affected by consumer spending trends.
Hot Growth Companies To Buy For 2015: Asta Funding Inc.(ASFI)
Asta Funding, Inc., together with its subsidiaries, engages in purchasing, managing, and servicing distressed consumer receivables in the United States. Its principal portfolio includes charged-off receivables consisting of accounts that have been written-off by the originators and might have been previously serviced by collection agencies; semi-performing receivables, including accounts where the debtor is currently making partial or irregular monthly payments, but the accounts might have been written-off by the originators; performing receivables comprising accounts where the debtor is making regular monthly payments that might or might not have been delinquent in the past; and distressed consumer receivables, such as the unpaid debts of individuals to banks, finance companies, and other credit and service providers. The company?s distressed consumer receivables consist of MasterCard, Visa, and other credit card accounts, which were charged-off by the issuers or provide rs for non-payment. Asta Funding, Inc. was founded in 1994 and is based in Englewood Cliffs, New Jersey.
Advisors' Opinion:- [By Tim Melvin]
There a lot of moving parts to Asta Funding (ASFI), but there appears to be a great deal of value that isn�� reflected in the current stock price. ASFI stock is trading at less than 65% of book value, but several of its debt collection assets are carried at zero cost basis and yet may have substantial value. The balance sheet is strong with more than $90 million in cash. ASFI has been moving into other businesses including disability claims to increase its growth opportunities over the next few years. It�� a fairly complex business, but it is very cheap — and the first sign of good news could send the shares a lot higher.
Top Shipping Companies To Buy Right Now: EXACT Sciences Corporation(EXAS)
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing a molecular diagnostic technology for the early detection and prevention of colorectal pre-cancer and cancer. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect each of the four stages of colorectal cancer, as well as pre-cancerous lesions. Its test includes proprietary and patented methods, which isolate and analyze the trace amounts of human DNA that are shed into stool every day from the exfoliation of cells that line the colon. The company?s Cologuard test is also used to detect blood in stool, utilizing an antibody-based fecal immunochemical test. It has a strategic alliance agreement with LabCorp under which it licenses its patents and patent applications relating to the stool-based colorectal cancer screening technology to LabCorp; a collaboration, license, and purchase agreement with Genzyme Corporation to d eliver intellectual property improvements through licenses; and a license agreement with MAYO Foundation for medical education and research. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of Exact Sciences (NASDAQ: EXAS) were down throughout Tuesday's session, falling 11.10 percent to $10.01, possibly linked to this being the first week its options are tradable. - [By Rich Smith]
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines feature a pair of optimistic notes urging investors to buy shares of Exact Sciences (NASDAQ: EXAS ) and Under Armour (NYSE: UA ) . Before we get to those two, however, a few words are in order on why...
Top Shipping Companies To Buy Right Now: Energen Corporation (EGN)
Energen Corporation, an energy holding company, engages in the development, acquisition, exploration, and production of oil, natural gas, and natural gas liquids in the continental United States. The company is also involved in the purchase, distribution, and sale of natural gas to residential, commercial, and industrial customers, as well as to other end-users of natural gas in central and north Alabama. In addition, it provides gas transportation services to industrial and commercial customers located on its distribution system. As of December 31, 2012, the company had approximately 750 million barrels of oil-equivalent proved, probable, and possible reserves. Energen Corporation was founded in 1929 and is headquartered in Birmingham, Alabama.
Advisors' Opinion:- [By Marc Bastow]
Oil and gas energy holding company Energen (EGN) raised its quarterly dividend 3.4% to 15 cents per share, payable on Mar. 3 to shareholder of record as of Feb. 14.
EGN Dividend Yield: 0.86% - [By Lauren Pollock]
Energen Corp.(EGN) said it expects last month’s severe weather in West Texas to weigh on results from the oil-and-gas production company’s Permian Basin operations.
Top Shipping Companies To Buy Right Now: Oberbank AG (OBV)
Oberbank AG is an Austria-based commercial regional bank. The Company provides products and services for individual customers, as well as for corporate customers. It divides its operations into four segments: Corporate Customers, Private Customers, Financial Markets and Others. The Company offers credit and debit cards, current and saving accounts, investment services, electronic banking services, as well as financing, leasing, investment and real estate services. It operates through numerous offices in Austria, Germany, the Czech Republic, Hungary and Slovakia. The Company�� major shareholder is CABO Beteiligungsgesellschafts mbH with a stake of 32.54%. Advisors' Opinion:- [By Tom Aspray]
The US market has not been immune to China shocks in 2013 as a plunge in the Japanese market on May 24 was a reaction in part to more weak manufacturing data out of China. But just a month later, the correction in the US market was over as it was no longer overbought (see chart). The weekly on-balance volume (OBV) on the bottom of the chart has continued to make higher highs, line a, since early in 2012.
Top Shipping Companies To Buy Right Now: Tetraphase Pharmaceuticals Inc (TTPH)
Tetraphase Pharmaceuticals, Inc., incorporated on July 7, 2006, is a clinical stage biopharmaceutical company. The Company�� product candidate, eravacycline, is a fully synthetic tetracycline derivative that the Company are developing as a broad-spectrum intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multi-drug resistant infections, including multi-drug resistant Gram-negative infections. The Company�� frequently used products, such as Zyvox and Cubicin, are limited to Gram-positive bacteria and thus are rarely used as a first-line empiric monotherapy if broad bacterial coverage is required. During the year ended December 31, 2012, completed a Phase 2 clinical trial of eravacycline with intravenous administration for the treatment of patients with complicated intra-abdominal infections, or cIAI, and are finalizing its pivotal Phase 3 program for eravacycline. In 2012, in vitro experiments, eravacycline has demonstrated the ability to cover a variety of multi-drug resistant Gram-negative, Gram-positive, anaerobic and atypical bacteria, including multi-drug resistant Klebsiella pneumoniae, the species of Gram-negative bacteria that killed seven patients at the Clinical Center of the National Institutes of Health.
Gram-positive bacteria that have developed resistance to existing drugs include: Streptococcus pneumoniae that cause pneumonia, ear infections, bloodstream infections and meningitis; Staphylococcus aureus that cause skin, bone, lung and bloodstream infections, and Enterococci that are responsible for infections transmitted in healthcare settings. Gram-negative bacteria that have developed resistance to existing drugs include: Escherichia coli that cause urinary tract, skin and bloodstream infections; Salmonella and Escherichia coli that cause foodborne infections, and Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella spp.
In addition, other antibiotics that have been used as first-line empiric monothe! rapies, such as Levaquin, piperacillin/tazobactam, which is marketed by Pfizer as Zosyn, carbapenems, such as Merrem, and imipenem/cilastatin, which is marketed by Merck as Primaxin, have seen their utility as first-line empiric monotherapies diminished as the number of bacterial strains resistant to these therapies has increased. In addition to developing an intravenous formulation of eravacycline, the Company is also developing an oral formulation. A number of previous tetracyclines have been available in both intravenous and oral dosage forms. Infections that are resistant to existing oral drugs are increasingly common, and the Company believe that an intravenous-to-oral step-down therapy in which patients are started on the intravenous formulation of eravacycline and then stepped down to an oral formulation of eravacycline could reduce the length of a patient�� hospital stay or help avoid hospital admission altogether, lowering the overall cost of care for these patients.
Advisors' Opinion:- [By Roberto Pedone]
Another under-$10 biopharmaceutical player that's starting to trend within range of triggering a near-term breakout trade is Tetraphase Pharmaceuticals (TTPH), which using its proprietary chemistry technology creates novel antibiotics for serious and life-threatening multi-drug resistant infections. This stock is off to a strong start in 2013, with shares up 19.4%.
If you take a look at the chart for Tetraphase Pharmaceuticals, you'll notice that this stock has just started to trend back above its 50-day moving average of $7.76 a share with decent upside volume flows. That move is quickly pushing shares of TTPH within range of breaking out above some key near-term overhead resistance levels that have acted as a ceiling for the stock for the last three months.
Market players should now look for long-biased trades in TTPH if it manages to break out above some near-term overhead resistance levels at $8.30 to $8.40 a share and then once it takes out more resistance at $8.50 to $9 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average volume of 62,234 shares. If that breakout triggers soon, then TTPH will set up to re-test or possibly take out its all-time high at $9.66 a share. Any high-volume move above that level will then push TTPH into new all-time high territory, which is bullish technical price action. Some possible upside targets off that move are $12 to $13 a share.
Traders can look to buy TTPH off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $7.76 a share, or below more key near-term support levels at $7.37 to $7.02 a share. One can also buy TTPH off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top Shipping Companies To Buy Right Now: WisdomTree International Dividend Ex Financial Fund (DOO)
WisdomTree International Dividend Top 100 Fund (The Fund) is a non-diversified fund. It seeks investment results that closely correspond to the price and yield performance, before fees and expenses, of the WisdomTree International Dividend Top 100 Index (The Index). The fund is managed by WisdomTree Asset Management, Inc.
The Index measures the performance of the 100 highest dividend-yielding companies in the WisdomTree International LargeCap Dividend Index. The Index is created by selecting the top 100 companies ranked by highest dividend yield from the WisdomTree International LargeCap Dividend Index.
Advisors' Opinion:- [By Eric Lam]
��ompanies that come to market are coming from sectors that work,��said Brian Huen, managing partner at Red Sky Capital Management Ltd. in Toronto. He helps manage C$220 million with the firm, and participated in the offerings for Choice Properties, Information Services Corp., and Ski-Doo maker BRP Inc. (DOO) ��eople certainly aren�� bringing any gold IPOs to market. So investors are focusing on buying deals in the right markets, as opposed to the wider market which has exposure to resources.��
Top Shipping Companies To Buy Right Now: Adept Technology Inc.(ADEP)
Adept Technology, Inc., together with its subsidiaries, provides intelligent robotics systems and services for packaging, solar, medical, disk drive/electronics, machine tool automation, and automotive electronics markets. Its product range includes application software, integrated real-time vision and multi-axis motion controls, machine vision systems and software, autonomous navigation software and controls, industrial robots and grippers, autonomous service robots, intelligent automated guided vehicles (AGVs), and advanced vision-based flexible parts feeders. The company offers 4-axis Cobra family of robots, which are designed for assembly and material handling tasks; Adept Quattro parallel robots for high-speed packaging, assembly, and loading/unloading applications; Adept Viper 6-axis articulated robots for high-speed precision assembly; Modular Adept Python single axis robot mechanisms; and mobile robots, including autonomous service robots and intelligent AGVs. It a lso provides support services to customers, including spare parts for and/or remanufacture of robot mechanisms; information regarding the use of its automation equipment; ongoing support for installed systems; consulting services for applications; and training courses ranging from system operation and maintenance to programming for manufacturing engineers, who design and implement automation lines. The company markets its products through its direct sales force, as well as through systems integrators, sales representatives, distributors, and original equipment manufacturers primarily in the United States, Europe, and Asia. Adept Technology, Inc. was founded in 1983 and is headquartered in Pleasanton, California.
Advisors' Opinion:- [By John Udovich]
Spruce Point Capital Management, LLC has released a research report about small cap robotics stock iRobot Corporation (NASDAQ: IRBT) entitled ��bout to Short Circuit,��meaning investors should take a closer look at the report, the�stock�and the performance of�robotics peer Adept Technology Inc (NASDAQ: ADEP) and�the Robo-Stox Global Robotics & Automation ETF (NASDAQ: ROBO). I should mention that we used to have both Adept Technology and iRobot Corporation in our SmallCap Network Elite Opportunity (SCN EO) portfolio�because we see the�robotics subsector improving as companies aim to reduce overhead and improve efficiencies through machine to machine (M2M) automation.
- [By MONEYMORNING.COM]
Michael's pick for 2014 was Adept Technology Inc. (Nasdaq: ADEP), a play on the red-hot robotics sector whose stock he predicted could zoom 50% to 100% because of improving finances and the potential for a takeover.
- [By CRWE]
Adept Technology, Inc. (Nasdaq:ADEP), a leading provider of intelligent robots and autonomous mobile solutions and services, reported the appointment of Cornerstone Technical Group (CTG) as its regional distributor covering the southeastern United States.
- [By John Udovich]
Small cap robotics stocks Adept Technology Inc (NASDAQ: ADEP) and iRobot Corporation (NASDAQ: IRBT) have both been putting in a great performance for investors, but which is the better robotics stock for�investors? I should mention that we have had Adept Technology in our SmallCap Network Elite Opportunity (SCN EO) portfolio since mid-September and we are already sitting on a 71.38% return so far plus we have just added iRobot Corporation to our portfolio because we see the�robotics subsector improving as companies aim to reduce overhead and improve efficiencies through machine to machine (M2M) automation.
No comments:
Post a Comment